HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis-Reference-Cited by-同舟云学术

HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis

Published:2017-07-11 Issue:9 Volume:11 Page:1225-1240
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Chen Shi-Lu¹²,Liu Li-Li¹²,Lu Shi-Xun¹²,Luo Rong-Zhen¹²,Wang Chun-Hua¹²,Wang Hong¹²,Cai Shao-Hang¹²,Yang Xia¹²,Xie Dan¹²,Zhang Chris Zhiyi¹²,Yun Jing-Ping¹²

Affiliation:

1. Sun Yat-Sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou China

2. Department of Pathology; Sun Yat-Sen University Cancer Center; Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference47 articles.

1. Molecular mechanisms of hepatocellular carcinoma;Aravalli;Hepatology,2008

2. Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches;Breuhahn;Hepatology,2011

3. Infection and cancer: the case of hepatitis B;Chan;J Clin Oncol,2016

4. AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model;Chen;Mol Cancer Ther,2006

5. Absent in melanoma 2 proteins in the development of cancer;Choubey;Cell Mol Life Sci,2016

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel role of AIM2 inflammasome-mediated pyroptosis in radiofrequency ablation of hepatocellular carcinoma;Annals of Hepatology;2024-11

2. Hepatocellular carcinoma and AIM2: Therapeutic potential through regulation of autophagy and macrophage polarization;Immunity, Inflammation and Disease;2024-09

3. The role of inflammasome in chronic viral hepatitis;Frontiers in Cellular and Infection Microbiology;2024-05-16

4. New insights into nucleic acid sensor AIM2: The potential benefit in targeted therapy for cancer;Pharmacological Research;2024-02

5. FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease;Hepatology International;2024-01-06